The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
Psilera Collaborates with Drug Development Leader Hesperos to Advance Preclinical Modeling of PSIL-006 for Frontotemporal Dementia PR Newswire ORLANDO, Fla. and TAMPA, Fla., June 9, 2025 ...
Ace Therapeutics announces its preclinical ophthalmic drug development services to help expedite the discovery of ...
Insilico Medicine has entered into a co-development collaboration agreement with Hygtia Therapeutics, with both parties each holding 50% of the global rights and interests to the program. In return, ...
Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...
Drug development is an unforgiving business. Discovering a novel molecule is difficult enough, but then it can take years of preclinical studies and molecular tweaking to mitigate a drug’s toxicity, ...
Jo Varshney, PhD, DVM, discusses how VeriSIM Life’s innovative approach leverages artificial intelligence and multispecies ...
AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
News-Medical.Net on MSN
AI-designed NLRP3 inhibitor receives FDA clearance for Parkinson disease trials
Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...
TORONTO and HAIFA, Israel, March 14, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce that it has successfully ...
The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results